Halo Commences Formal EU GACP Certification Process for Cannabis Grown at Bophelo in Lesotho, Africa

Nachrichtenquelle: Business Wire (engl.)
15.01.2020, 22:30  |  534   |   |   

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce Bophelo Bioscience & Wellness (“Bophelo”) has formally commenced the certification process required to achieve European Good Agricultural and Collection Practices (“EU GACP”) accreditation for cannabis grown at the Company’s 205-hectare cultivation site at Bophelo in Lesotho, Africa.

Obtaining EU GACP certification would allow Halo to export medicinal cannabis and Cannabis-Based Products for Medicinal use (“CBPMs”) to the United Kingdom as well as countries in the European Union. According to Prohibition Partners, the CBPM market in the UK is comprised of 1.4 million consumers who use CBPMs for health treatments with an additional 4.7 million recreational cannabis users. This translate to a medical cannabis market that is predicted to be worth roughly $1.3 billion by 2024.

To achieve EU GACP accreditation, Halo has engaged Pharmaconsulta Limited (“Pharmaconsulta”), an independent firm based out of Malta in Europe, that specializes in pharmaceutical regulatory affairs.

Pharmaconsulta will implement a comprehensive quality control program to ensure that cannabis grown at Bophelo may be exported to various legal international markets. The firm will ensure the following milestones are completed:

  • Obtain an EU GACP certificate for Bophelo, as well as meet the requirements and standards for starting materials of Herbal Origin, as published by the European Medicines Agency (“EMEA”) and World Health Organization (“WHO”) guidelines on GACP for medicinal plants
  • Provide full audits on the agricultural and cultivation sites in Lesotho, Africa
  • Draft and implement a quality control system compliant with EU GACP standards
  • Provide all necessary training to the Bophelo staff

Kiran Sidhu, CEO and Co-Founder of Halo, commented, “We are excited to finalize the steps required to export medical cannabis products from Lesotho into Europe. Becoming GACP certified and meeting all necessary standards is critical in our execution internationally. Pharmaconsulta will ensure that the Bophelo facilities receive all permits for exporting medicinal cannabis to the United Kingdom through Halo’s planned acquisition target Canmart Limited.”

Seite 1 von 3
Halo Labs Aktie jetzt für 4€ handeln - auf Smartbroker.de



Diesen Artikel teilen

Diskussion: Cannabis ? Jetzt aber Halo !
Wertpapier

Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
EuroCannabisCerWHOMalta


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel